Antibody formulation
US6991790B1 · kind B1 · utility
47Cited by
21References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2000 |
| Grant date | Jan 31, 2006 |
| Priority date | — |
| Expiry date | Jan 19, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of antibody not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.0, a surfactant and a polyol is described, along with uses for such a formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.